These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8659193)

  • 21. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
    Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
    Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary artery bypass surgery and percutaneous transluminal coronary angioplasty in patients with multivessel disease.
    Van Domburg RT; Saia F; Lemos PA
    Minerva Cardioangiol; 2003 Oct; 51(5):599-608. PubMed ID: 14551527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective and efficient strategies for coronary revascularization in the drug-eluting stent era.
    Lepor NE; Madyoon H; Kereiakes D
    Rev Cardiovasc Med; 2002; 3 Suppl 5():S38-50. PubMed ID: 12478234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy).
    Weisz G; Moses JW; Teirstein PS; Holmes DR; Raizner AE; Satler LF; Mishkel G; Wilensky RL; Wang P; Kuntz RE; Popma JJ; Leon MB
    Am J Cardiol; 2007 Apr; 99(8):1044-50. PubMed ID: 17437725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intramural drug delivery by direct injection within the arterial wall: first clinical experience with a novel intracoronary delivery-infiltrator system.
    Pavlides GS; Barath P; Maginas A; Vasilikos V; Cokkinos DV; O'Neill WW
    Cathet Cardiovasc Diagn; 1997 Jul; 41(3):287-92. PubMed ID: 9213027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local drug delivery: an emerging approach in the treatment of restenosis.
    Ettenson DS; Edelman ER
    Vasc Med; 2000; 5(2):97-102. PubMed ID: 10943586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local delivery of biodegradable microparticles containing colchicine or a colchicine analogue: effects on restenosis and implications for catheter-based drug delivery.
    Gradus-Pizlo I; Wilensky RL; March KL; Fineberg N; Michaels M; Sandusky GE; Hathaway DR
    J Am Coll Cardiol; 1995 Nov; 26(6):1549-57. PubMed ID: 7594084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The three processes leading to post PTCA restenosis: dependence on the lesion substrate.
    Fuster V; Falk E; Fallon JT; Badimon L; Chesebro JH; Badimon JJ
    Thromb Haemost; 1995 Jul; 74(1):552-9. PubMed ID: 8578523
    [No Abstract]   [Full Text] [Related]  

  • 29. Local delivery of heparin to balloon angioplasty sites with a new angiotherapy catheter: pharmacokinetics and effect on platelet deposition in the porcine model.
    Fram DB; Mitchel JF; Azrin MA; Chow MS; Waters DD; McKay RG
    Cathet Cardiovasc Diagn; 1997 Jul; 41(3):275-86. PubMed ID: 9213026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug delivery system in cardiovascular drugs].
    Miyake F; Kamogawa A; Sakakibara M
    Nihon Rinsho; 1998 Mar; 56(3):737-41. PubMed ID: 9549366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treating atherosclerosis: local drug delivery from laboratory studies to clinical trials.
    Gershlick AH
    Atherosclerosis; 2002 Feb; 160(2):259-71. PubMed ID: 11849647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retractable-needle catheters: an update on local drug delivery in coronary interventions.
    Angelini P; Bandula W
    Tex Heart Inst J; 2008; 35(4):419-24. PubMed ID: 19156235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new approach for local intravascular drug delivery. Iontophoretic balloon.
    Fernández-Ortiz A; Meyer BJ; Mailhac A; Falk E; Badimon L; Fallon JT; Fuster V; Chesebro JH; Badimon JJ
    Circulation; 1994 Apr; 89(4):1518-22. PubMed ID: 8149516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of intracoronary local adhesive delivery technique.
    Sonobe T; Naganuma S; Yambe T; Kobayashi SI; Sizuka K; Katahira Y; Nitta K; Nitta SI
    Int J Artif Organs; 1997 Jun; 20(6):319-26. PubMed ID: 9259208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local drug delivery: current applications.
    Bailey SR
    Prog Cardiovasc Dis; 1997; 40(2):183-204. PubMed ID: 9327832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of vascular disease with local drug delivery systems.
    Makkar RR; Litvack F; Eigler N; Forrester JS
    Cardiologia; 1995 Sep; 40(9):651-7. PubMed ID: 8542617
    [No Abstract]   [Full Text] [Related]  

  • 37. [Local drug delivery and gene therapy].
    Darius H; Buerke M; Boissel JP; Grosser T; Veit K; Zacharowski K; Meyer J
    Herz; 1997 Dec; 22(6):347-54. PubMed ID: 9483440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endovascular manipulation to restrict restenosis.
    Gershlick AH
    Vasc Med; 1998; 3(3):177-88. PubMed ID: 9892510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical aspects and therapy of angina pectoris and of coronary occlusion].
    Hueber EF
    Wien Z Inn Med; 1965 Oct; 46(10):421-30. PubMed ID: 5881289
    [No Abstract]   [Full Text] [Related]  

  • 40. Plaque stabilisation by systemic and local drug administration.
    Spratt JC; Camenzind E
    Heart; 2004 Dec; 90(12):1392-4. PubMed ID: 15547009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.